MENU

Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11

Pfizer's application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story